UniProt ID | CHRD1_HUMAN | |
---|---|---|
UniProt AC | Q9UHD1 | |
Protein Name | Cysteine and histidine-rich domain-containing protein 1 | |
Gene Name | CHORDC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 332 | |
Subcellular Localization | ||
Protein Description | Regulates centrosome duplication, probably by inhibiting the kinase activity of ROCK2. Proposed to act as co-chaperone for HSP90. May play a role in the regulation of NOD1 via a HSP90 chaperone complex. In vitro, has intrinsic chaperone activity. This function may be achieved by inhibiting association of ROCK2 with NPM1. Involved in stress response. Prevents tumorigenesis.. | |
Protein Sequence | MALLCYNRGCGQRFDPETNSDDACTYHPGVPVFHDALKGWSCCKRRTTDFSDFLSIVGCTKGRHNSEKPPEPVKPEVKTTEKKELCELKPKFQEHIIQAPKPVEAIKRPSPDEPMTNLELKISASLKQALDKLKLSSGNEENKKEEDNDEIKIGTSCKNGGCSKTYQGLESLEEVCVYHSGVPIFHEGMKYWSCCRRKTSDFNTFLAQEGCTKGKHMWTKKDAGKKVVPCRHDWHQTGGEVTISVYAKNSLPELSRVEANSTLLNVHIVFEGEKEFDQNVKLWGVIDVKRSYVTMTATKIEITMRKAEPMQWASLELPAAKKQEKQKDATTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALLCYNRG ------CCEEECCCC | 14.83 | 22814378 | |
8 | Methylation | MALLCYNRGCGQRFD CCEEECCCCCCCCCC | 18.46 | - | |
18 | Phosphorylation | GQRFDPETNSDDACT CCCCCCCCCCCCCCC | 45.47 | 28348404 | |
18 | Ubiquitination | GQRFDPETNSDDACT CCCCCCCCCCCCCCC | 45.47 | 27667366 | |
20 | Phosphorylation | RFDPETNSDDACTYH CCCCCCCCCCCCCCC | 44.26 | 25159151 | |
20 | Ubiquitination | RFDPETNSDDACTYH CCCCCCCCCCCCCCC | 44.26 | 27667366 | |
25 | Phosphorylation | TNSDDACTYHPGVPV CCCCCCCCCCCCCCC | 26.95 | 28348404 | |
26 | Phosphorylation | NSDDACTYHPGVPVF CCCCCCCCCCCCCCC | 13.10 | 27642862 | |
29 | Ubiquitination | DACTYHPGVPVFHDA CCCCCCCCCCCCHHH | 24.05 | 27667366 | |
38 | 2-Hydroxyisobutyrylation | PVFHDALKGWSCCKR CCCHHHHCCCCCCCC | 61.12 | - | |
38 | Acetylation | PVFHDALKGWSCCKR CCCHHHHCCCCCCCC | 61.12 | 27452117 | |
41 | Phosphorylation | HDALKGWSCCKRRTT HHHHCCCCCCCCCCC | 20.50 | - | |
44 | 2-Hydroxyisobutyrylation | LKGWSCCKRRTTDFS HCCCCCCCCCCCCHH | 49.60 | - | |
47 | Phosphorylation | WSCCKRRTTDFSDFL CCCCCCCCCCHHHHH | 34.45 | 30266825 | |
48 | Phosphorylation | SCCKRRTTDFSDFLS CCCCCCCCCHHHHHH | 32.98 | 30266825 | |
51 | Phosphorylation | KRRTTDFSDFLSIVG CCCCCCHHHHHHHHC | 30.20 | 10571178 | |
55 | Phosphorylation | TDFSDFLSIVGCTKG CCHHHHHHHHCCCCC | 18.41 | 23403867 | |
55 | Ubiquitination | TDFSDFLSIVGCTKG CCHHHHHHHHCCCCC | 18.41 | 33845483 | |
59 | Glutathionylation | DFLSIVGCTKGRHNS HHHHHHCCCCCCCCC | 2.17 | 22555962 | |
60 | Phosphorylation | FLSIVGCTKGRHNSE HHHHHCCCCCCCCCC | 30.52 | 23403867 | |
64 | Ubiquitination | VGCTKGRHNSEKPPE HCCCCCCCCCCCCCC | 51.33 | 29967540 | |
66 | Phosphorylation | CTKGRHNSEKPPEPV CCCCCCCCCCCCCCC | 40.65 | 28555341 | |
68 | Ubiquitination | KGRHNSEKPPEPVKP CCCCCCCCCCCCCCC | 66.74 | 33845483 | |
70 | Ubiquitination | RHNSEKPPEPVKPEV CCCCCCCCCCCCCCC | 70.37 | 27667366 | |
72 | Ubiquitination | NSEKPPEPVKPEVKT CCCCCCCCCCCCCCC | 45.25 | 21890473 | |
72 (in isoform 2) | Ubiquitination | - | 45.25 | 21890473 | |
74 | Acetylation | EKPPEPVKPEVKTTE CCCCCCCCCCCCCCC | 46.29 | 26051181 | |
74 | Ubiquitination | EKPPEPVKPEVKTTE CCCCCCCCCCCCCCC | 46.29 | 33845483 | |
79 | Phosphorylation | PVKPEVKTTEKKELC CCCCCCCCCCCHHHH | 45.42 | 28555341 | |
82 | Ubiquitination | PEVKTTEKKELCELK CCCCCCCCHHHHHCC | 49.83 | 29967540 | |
83 | 2-Hydroxyisobutyrylation | EVKTTEKKELCELKP CCCCCCCHHHHHCCH | 50.08 | - | |
83 | Ubiquitination | EVKTTEKKELCELKP CCCCCCCHHHHHCCH | 50.08 | 29967540 | |
86 | Glutathionylation | TTEKKELCELKPKFQ CCCCHHHHHCCHHHH | 6.37 | 22555962 | |
88 | Ubiquitination | EKKELCELKPKFQEH CCHHHHHCCHHHHHH | 12.88 | 29967540 | |
89 | Acetylation | KKELCELKPKFQEHI CHHHHHCCHHHHHHH | 24.70 | 23749302 | |
89 | Malonylation | KKELCELKPKFQEHI CHHHHHCCHHHHHHH | 24.70 | 26320211 | |
89 | Ubiquitination | KKELCELKPKFQEHI CHHHHHCCHHHHHHH | 24.70 | 27667366 | |
91 | Acetylation | ELCELKPKFQEHIIQ HHHHCCHHHHHHHCC | 59.08 | 23236377 | |
91 | Ubiquitination | ELCELKPKFQEHIIQ HHHHCCHHHHHHHCC | 59.08 | 22817900 | |
91 (in isoform 1) | Ubiquitination | - | 59.08 | 21890473 | |
101 | Acetylation | EHIIQAPKPVEAIKR HHHCCCCCCHHHCCC | 65.79 | 26051181 | |
101 | Ubiquitination | EHIIQAPKPVEAIKR HHHCCCCCCHHHCCC | 65.79 | 29967540 | |
102 | Ubiquitination | HIIQAPKPVEAIKRP HHCCCCCCHHHCCCC | 28.28 | 32015554 | |
107 | Acetylation | PKPVEAIKRPSPDEP CCCHHHCCCCCCCCC | 66.36 | 26051181 | |
107 | Ubiquitination | PKPVEAIKRPSPDEP CCCHHHCCCCCCCCC | 66.36 | 29967540 | |
108 | Ubiquitination | KPVEAIKRPSPDEPM CCHHHCCCCCCCCCC | 30.71 | 32015554 | |
110 | Phosphorylation | VEAIKRPSPDEPMTN HHHCCCCCCCCCCCC | 49.36 | 28464451 | |
113 | Ubiquitination | IKRPSPDEPMTNLEL CCCCCCCCCCCCCCH | 40.11 | 27667366 | |
115 | Sulfoxidation | RPSPDEPMTNLELKI CCCCCCCCCCCCHHH | 3.50 | 21406390 | |
115 | Ubiquitination | RPSPDEPMTNLELKI CCCCCCCCCCCCHHH | 3.50 | 27667366 | |
116 | Phosphorylation | PSPDEPMTNLELKIS CCCCCCCCCCCHHHC | 47.57 | 20068231 | |
121 | Ubiquitination | PMTNLELKISASLKQ CCCCCCHHHCHHHHH | 25.82 | 32015554 | |
124 | Ubiquitination | NLELKISASLKQALD CCCHHHCHHHHHHHH | 23.50 | 33845483 | |
125 | Phosphorylation | LELKISASLKQALDK CCHHHCHHHHHHHHH | 29.34 | 28464451 | |
125 | Ubiquitination | LELKISASLKQALDK CCHHHCHHHHHHHHH | 29.34 | 33845483 | |
127 | Acetylation | LKISASLKQALDKLK HHHCHHHHHHHHHHC | 30.91 | 25953088 | |
127 | Succinylation | LKISASLKQALDKLK HHHCHHHHHHHHHHC | 30.91 | 23954790 | |
127 | Ubiquitination | LKISASLKQALDKLK HHHCHHHHHHHHHHC | 30.91 | 32015554 | |
132 | 2-Hydroxyisobutyrylation | SLKQALDKLKLSSGN HHHHHHHHHCCCCCC | 48.66 | - | |
132 | Acetylation | SLKQALDKLKLSSGN HHHHHHHHHCCCCCC | 48.66 | 25953088 | |
132 | Ubiquitination | SLKQALDKLKLSSGN HHHHHHHHHCCCCCC | 48.66 | 27667366 | |
133 | Ubiquitination | LKQALDKLKLSSGNE HHHHHHHHCCCCCCC | 7.24 | 33845483 | |
134 | Ubiquitination | KQALDKLKLSSGNEE HHHHHHHCCCCCCCC | 52.65 | 27667366 | |
136 | Phosphorylation | ALDKLKLSSGNEENK HHHHHCCCCCCCCCC | 34.31 | 25159151 | |
137 | Phosphorylation | LDKLKLSSGNEENKK HHHHCCCCCCCCCCC | 56.95 | 25159151 | |
143 | Ubiquitination | SSGNEENKKEEDNDE CCCCCCCCCCCCCCC | 65.91 | 33845483 | |
144 | Ubiquitination | SGNEENKKEEDNDEI CCCCCCCCCCCCCCE | 77.30 | 33845483 | |
152 | Ubiquitination | EEDNDEIKIGTSCKN CCCCCCEEECCCCCC | 32.79 | 33845483 | |
175 | Ubiquitination | GLESLEEVCVYHSGV CHHCHHHHEECCCCC | 1.63 | 21890473 | |
178 | Phosphorylation | SLEEVCVYHSGVPIF CHHHHEECCCCCEEE | 5.78 | - | |
179 | Ubiquitination | LEEVCVYHSGVPIFH HHHHEECCCCCEEEC | 9.55 | 29967540 | |
194 | Ubiquitination | EGMKYWSCCRRKTSD CCHHHHHHHCCCCCC | 0.98 | 33845483 | |
198 | Acetylation | YWSCCRRKTSDFNTF HHHHHCCCCCCHHHH | 32.78 | 20167786 | |
198 | Ubiquitination | YWSCCRRKTSDFNTF HHHHHCCCCCCHHHH | 32.78 | 29967540 | |
199 | Phosphorylation | WSCCRRKTSDFNTFL HHHHCCCCCCHHHHH | 31.55 | 30266825 | |
200 | Phosphorylation | SCCRRKTSDFNTFLA HHHCCCCCCHHHHHH | 43.15 | 30266825 | |
204 | Phosphorylation | RKTSDFNTFLAQEGC CCCCCHHHHHHHCCC | 21.73 | 30266825 | |
212 | Phosphorylation | FLAQEGCTKGKHMWT HHHHCCCCCCCCCEE | 54.40 | 23403867 | |
213 | Ubiquitination | LAQEGCTKGKHMWTK HHHCCCCCCCCCEEE | 70.77 | 33845483 | |
215 | Acetylation | QEGCTKGKHMWTKKD HCCCCCCCCCEEECC | 31.66 | 26051181 | |
215 | Ubiquitination | QEGCTKGKHMWTKKD HCCCCCCCCCEEECC | 31.66 | - | |
220 | Acetylation | KGKHMWTKKDAGKKV CCCCCEEECCCCCEE | 32.89 | 20167786 | |
237 | Phosphorylation | CRHDWHQTGGEVTIS CCCCCCCCCCEEEEE | 33.98 | 21406692 | |
242 | Phosphorylation | HQTGGEVTISVYAKN CCCCCEEEEEEEECC | 11.84 | 21406692 | |
244 | Phosphorylation | TGGEVTISVYAKNSL CCCEEEEEEEECCCC | 10.34 | 21406692 | |
246 | Phosphorylation | GEVTISVYAKNSLPE CEEEEEEEECCCCCC | 12.69 | 21406692 | |
270 | Ubiquitination | LLNVHIVFEGEKEFD EEEEEEEECCCCEEC | 11.18 | 23000965 | |
270 (in isoform 2) | Ubiquitination | - | 11.18 | 21890473 | |
289 | 2-Hydroxyisobutyrylation | LWGVIDVKRSYVTMT EEEEEEEECCEEEEE | 31.70 | - | |
289 | Acetylation | LWGVIDVKRSYVTMT EEEEEEEECCEEEEE | 31.70 | 25953088 | |
289 | Ubiquitination | LWGVIDVKRSYVTMT EEEEEEEECCEEEEE | 31.70 | 23000965 | |
289 (in isoform 1) | Ubiquitination | - | 31.70 | 21890473 | |
291 | Phosphorylation | GVIDVKRSYVTMTAT EEEEEECCEEEEEEE | 20.45 | 28152594 | |
292 | Nitration | VIDVKRSYVTMTATK EEEEECCEEEEEEEE | 12.17 | - | |
292 | Phosphorylation | VIDVKRSYVTMTATK EEEEECCEEEEEEEE | 12.17 | 28152594 | |
294 | Phosphorylation | DVKRSYVTMTATKIE EEECCEEEEEEEEEE | 10.69 | 28152594 | |
295 | Sulfoxidation | VKRSYVTMTATKIEI EECCEEEEEEEEEEE | 1.39 | 30846556 | |
296 | Phosphorylation | KRSYVTMTATKIEIT ECCEEEEEEEEEEEE | 23.08 | 28152594 | |
298 | Phosphorylation | SYVTMTATKIEITMR CEEEEEEEEEEEEEE | 24.32 | 28152594 | |
302 | Ubiquitination | MTATKIEITMRKAEP EEEEEEEEEEEECCC | 4.11 | 32015554 | |
310 | Sulfoxidation | TMRKAEPMQWASLEL EEEECCCCCHHHCCC | 3.80 | 28183972 | |
314 | Phosphorylation | AEPMQWASLELPAAK CCCCCHHHCCCCHHH | 21.29 | 25159151 | |
321 | Acetylation | SLELPAAKKQEKQKD HCCCCHHHHHHHHHC | 58.03 | 25953088 | |
321 | Ubiquitination | SLELPAAKKQEKQKD HCCCCHHHHHHHHHC | 58.03 | 32015554 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHRD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHRD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHRD1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-200, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-200, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-47 AND SER-51, AND MASSSPECTROMETRY. |